Literature DB >> 6293506

Selective activation of the converting enzyme inhibitor MK 421 and comparison of its active diacid form with captopril in different tissues of the rat.

T Unger, B Schüll, W Rascher, R E Lang, D Ganten.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6293506     DOI： 10.1016/0006-2952(82)90081-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  16 in total

Review 1.  Preclinical studies on angiotensin converting enzyme inhibitors.

Authors:  I L Natoff
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

2.  Demonstration of Ri-type adenosine receptors in bovine myocardium by radioligand binding.

Authors:  M J Lohse; D Ukena; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

3.  Nocturnal oscillations in plasma renin activity during sleep in hypertensive patients: the influence of perindopril.

Authors:  G Brandenberger; J L Imbs; J P Libert; J Ehrhart; C Simon; J P Santoni; M Follenius
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

Review 4.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  P A Todd; R C Heel
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

5.  The serum angiotensin-converting enzyme and angiotensin II response to altered posture and acute exercise, and the influence of ACE genotype.

Authors:  David Woods; Julie Sanders; Alun Jones; Emma Hawe; Peter Gohlke; Steve E Humphries; John Payne; Hugh Montgomery
Journal:  Eur J Appl Physiol       Date:  2003-11-01       Impact factor: 3.078

6.  Disposition of quinapril and quinaprilat in the isolated perfused rat kidney.

Authors:  A R Kugler; S C Olson; D E Smith
Journal:  J Pharmacokinet Biopharm       Date:  1995-06

Review 7.  Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney.

Authors:  G P Reams; J H Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

8.  Ramipril-induced decrease in renal lithium excretion in the rat.

Authors:  M Barthelmebs; M Grima; J L Imbs
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

9.  Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery.

Authors:  K Chiba; S Moriyama; Y Ishigai; A Fukuzawa; K Irie; T Shibano
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

10.  Renal protective effect of long term antihypertensive therapy with enalapril.

Authors:  J H Bauer; G P Reams
Journal:  Drugs       Date:  1988       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.